Enzo Biochem (ENZB) Total Assets by Year
Enzo Biochem Inc closed fiscal year 2024 with $85.8M in total assets, $29.7M in total liabilities and $56.1M in shareholder equity. Total assets fell 29.6% from the prior fiscal year. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Enzo Biochem Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ENZB Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing | FY17Filing | FY16Filing | FY15Filing | FY14Filing | FY13Filing | FY12Filing | FY11Filing | FY10Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $85.8M-29.6% | $121.9M+61.2% | $75.6M-33.5% | $113.7M+1.0% | $112.5M+5.5% | $106.6M+4.9% | $101.7M-5.6% | $107.7M-3.7% | $111.8M+63.5% | $68.4M+6.2% | $64.4M+9.2% | $59.0M-14.7% | $69.1M-36.9% | $109.5M | N/A |
| Total Liabilities | $29.7M-31.7% | $43.4M+105.3% | $21.1M-53.1% | $45.1M-16.7% | $54.2M+162.7% | $20.6M+0.4% | $20.5M+9.3% | $18.8M-15.6% | $22.3M-13.7% | $25.8M-6.1% | $27.5M+10.6% | $24.8M+24.0% | $20.0M-3.6% | $20.8M | N/A |
| Total Equity | $56.1M-28.5% | $78.5M+44.1% | $54.5M-20.6% | $68.6M+17.5% | $58.4M-32.1% | $86.0M+6.0% | $81.1M-8.7% | $88.9M-0.8% | $89.6M+110.2% | $42.6M+15.3% | $37.0M+8.3% | $34.1M-30.5% | $49.1M-44.7% | $88.7M-8.6% | $97.0M |
ENZB Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing | Q3'23Filing | Q2'23Filing | Q1'23Filing | Q4'22Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $63.5M-32.0% | $67.5M-31.9% | $75.3M-29.2% | $85.8M-29.6% | $93.5M+29.7% | $99.1M+29.6% | $106.3M+24.8% | $121.9M+61.2% | $72.1M-30.6% | $76.5M-29.7% | $85.2M-21.2% | $75.6M-33.5% |
| Total Liabilities | $20.1M-17.7% | $20.9M-26.2% | $27.6M-13.7% | $29.7M-31.7% | $24.4M-54.0% | $28.3M-35.1% | $32.0M-20.3% | $43.4M+105.3% | $53.1M+27.4% | $43.6M-0.2% | $40.2M-2.8% | $21.1M-53.1% |
| Total Equity | $43.4M-37.1% | $46.6M-34.1% | $47.7M-35.8% | $56.1M-28.5% | $69.0M+264.7% | $70.8M+115.6% | $74.3M+65.1% | $78.5M+44.1% | $18.9M-69.6% | $32.8M-49.6% | $45.0M-32.6% | $54.5M-20.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Enzo Biochem Inc financials
Frequently Asked Questions
Enzo Biochem Inc closed fiscal year 2024 with $85.8M in total assets, $29.7M in total liabilities and $56.1M in shareholder equity.
Enzo Biochem Inc (ENZB) total assets fell by 29.6% year over year, from $121.9M to $85.8M in fiscal year 2024.
Enzo Biochem Inc (ENZB) reported $63.5M in total assets in Q3 2025. This represents a decrease of 32.0% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Enzo Biochem Inc (ENZB) reported on that line in every period on record.